Forum for Innovative Regenerative Medicine of Japan visits CMBA on June 3rd, which is represented by Mr. Zhang Wanjun, the president of Fuji Biotech (Shanghai). Company. Li Shaoli, vice president of CMBA and Wu Zhaohui, general-secretary of CMBA friendly talk with Mr/ Zhang to discuss how to find the cooperation point of both organizations and promote the development of Asian Pacific region’s biotherapy for its administration, technology and industry.

The Forum for Innovative Regenerative Medicine (FIRM) was incorporated to quickly establish social systems to ensure safe and stable access to the benefits of research into regenerative medicine.